Patents Assigned to ABL BIO INCORPORATED
  • ANTIBODIES FOR TREATING ALPHA-SYNUCLEINOPATHIES
    Publication number: 20250059266
    Abstract: The present disclosure provides isolated binding proteins such as humanized antibodies and antigen-binding fragments thereof that target alpha-synuclein, including multispecific isolated binding proteins that target both alpha-synuclein and insulin-like growth factor 1 receptor. Also provided are methods of using the binding proteins to treat alpha-synucleinopathies.
    Type: Application
    Filed: November 6, 2024
    Publication date: February 20, 2025
    Applicant: ABL BIO INCORPORATED
    Inventors: Sungwon AN, Dongin KIM, Jung-Won SHIN, Donghwan KIM, Hyesu YUN, Jinhyung AHN, Byungje SUNG, Yong-Gyu SON, Jinwon JUNG, Bora LEE, Daehae SONG, Youngdon PAK, Kyungjin PARK, Juhee KIM
  • ANTIBODIES FOR TREATING ALPHA-SYNUCLEINOPATHIES
    Publication number: 20220380446
    Abstract: The present disclosure provides isolated binding proteins such as humanized antibodies and antigen-binding fragments thereof that target alpha-synuclein, including multispecific isolated binding proteins that target both alpha-synuclein and insulin-like growth factor 1 receptor. Also provided are methods of using the binding proteins to treat alpha-synucleinopathies.
    Type: Application
    Filed: May 12, 2022
    Publication date: December 1, 2022
    Applicant: ABL BIO INCORPORATED
    Inventors: Jinhyung AHN, Sungwon AN, Dongin KIM, Eunsil SUNG, Jaehyun EOM, Sang Hoon LEE, Seung-Jae LEE, Tae Kyung KIM, Min Sun CHOI, Weonkyoo YOU, Jaeho JUNG, Juhee KIM, Jinwon JUNG, Yeunju KIM, Yonggyu SON, Byungje SUNG